Age: 11.0
Sex: M
Vaccine: HPV4
Symptoms: Nervous system disorder, Neuralgia, Palpitations, Postural orthostatic tachycardia syndrome, Seizure
Clinical narrative: High cerebrospinal fluid pressure; suffered sporadic hearing and vision loss; suffered sporadic hearing and vision loss; autoimmune disorder; seizures; Would be aggressive or exhibit dangerous behavior, angry outbursts, aggression; On December 17, 2019, Plaintiff had his second Gardasil vaccination.; syncope/fainting, sometimes remaining unconscious for as long as 30 minutes at a time, lose consciousness daily; diarrhea; began staggering when he walked; unable to stand; gastroparesis/stomach pains, vomiting daily; fibromyalgia, joint and muscle pain, nerve pain, trouble sleeping, anxiety, depression; postural orthostatic tachycardia syndrome (POTS)/dysautonomia/fatigue,light-headedness,confusion,heart palpitations; mood swings; Information has been received from a lawyer, regarding a case in litigation and concerning a male patient (pt) of an unknown age. No other information concerning the pt's medical history, concurrent conditions or concomitant medications was provided.  On 09-NOV-2018, at the age of 11 years old, the pt received his first dose of quadrivalent human papillomavirus (HPV) (types 6,11,16,18) recomb. vaccine (GARDASIL) (dose, route of administration, anatomical location, lot # and expiration date were not reported) for preventing cancer. Almost immediately after receiving this vaccination, the pt began to experience fatigue and anxiety, as well as mood swings, trouble sleeping, light-headedness and confusion. Over the following months, these symptoms continued, and, in January 2019, the pt began to have more severe anxiety and depression. On 11-MAR-2019, the family sought help for the pt with a counselor and, later that month, a psychiatrist. On an unspecified date in 2019, along with his anxiety and depression, the pt continued to experience stomach pains and light-headedness. On an unspecified date in April 2019, he began vomiting daily and had diarrhea. On an unspecified date in May 2019, the pt was diagnosed with gastroparesis at a hospital. Over the summer, the vomiting stopped, although the pt continued to have anxiety, depression and trouble sleeping. On 08-SEP-2019, he began vomiting again, which continued for weeks. Later that month, on an unspecified date in September 2019, the pt began fainting, sometimes remaining unconscious for as long as 30 minutes at a time. On 01-OCT-2019, he fainted on his front lawn while waiting for the school bus. On an unspecified date in October 2019, the pt was seen at a clinic, where he was diagnosed with dysautonomia and postural orthostatic tachycardia syndrome (POTS) after a tilt table test. The pt was prescribed new medication, but he continued to have fainting spells. Soon thereafter, on an unspecified date in 2019, he began staggering when he walked and, eventually, was unable to stand. On 17-DEC-2019, the pt received his second dose of quadrivalent human papillomavirus (HPV) (types 6,11,16,18) recomb. vaccine (GARDASIL) (dose, route of administration, anatomical location, lot # and expiration date were not reported) (inappropriate schedule of vaccine administered). Thereafter, on an unspecified date, he suffered sporadic hearing and vision loss, and continued to lose consciousness daily. The family sought additional treatment of the pt's condition in February 2020. The doctor adjusted some of the pt's medications and ordered intravenous (IV) fluid therapy. Over the following months, the pt experienced numerous instances where he would faint and, upon walking, would be aggressive or exhibit dangerous behavior. Once he recovered, he would not remember these episodes. As the months progressed, so did the pt's symptoms. He was seen by physicians and specialists for his complaints which included joint and muscle pain, nerve pain, inability to walk, syncope, seizures, heart palpitations. The pt was confined to a wheelchair for a year and half. On 16-NOV-2020, the pt was unresponsive after having another syncope episode and was taken to the emergency room (ER). On 11-DEC-2020, the pt had a lumbar puncture, which showed a high cerebrospinal fluid (CSF) pressure. He returned to the hospital a few times over the next three months to address and treat the elevated pressure. On an unspecified date in April 2021, the pt began sessions with a therapist using system. The pt was required to undergo extensive physical therapy to regain his ability to walk and run. As a result of his post-quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) symptoms, the pt was unable to engage in activities that a young person would normally enjoy. He could no longer be physically active or participate in activities he previously was able to do. The pt struggled to keep up with his studies and had been receiving homebound education services for at least three years. His latest labs showed significant inflammation in his body. Based upon his chronic and severe post-quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) symptoms, the pt was diagnosed with various medical conditions, including but not limited to, POTS, dysautonomia, fibromyalgia, and gastroparesis. The pt contended that his quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) injection(s) caused him to develop serious and debilitating autoimmune, autonomic, and neurological, injuries, including but not limited to POTS, dysautonomia, fibromyalgia, and gastroparesis, which have resulted in the pt experiencing fatigue, severe anxiety and depression, mood swings, angry outbursts, aggression, joint and muscle pain, nerve pain, inability to walk, syncope, seizures, heart palpitations, trouble sleeping, light-headedness, confusion, stomach pains, vomiting and diarrhea, as well as a constellation of adverse symptoms, complications, injuries, and other adverse events, many of which are alleged herein and all of which were caused by quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) or otherwise linked to his quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL)-induced autoimmune disorder. The pt had suffered and at the time of report continued to suffer severe and permanent physical injuries, and associated symptomatology and had suffered severe and permanent emotional injuries, including pain and suffering. He also had a substantial fear of suffering additional and ongoing harms, including but not limited to now being at an increased risk of cancer, and future symptoms and harms associated with his injuries caused by quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL). As a direct and proximate result of his quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL)-induced injuries, the pt suffered and at the time of report continued to suffer economic losses, including considerable financial expenses for medical care and treatment, and diminished income capacity, and he would continue to incur these losses and expenses in the future. The outcome of the events of CSF pressure increased, POTS, gastroparesis, fibromyalgia, aggression, gait disturbance, dysstasia, deafness, blindness, mood swings, autoimmune disorder, seizure, diarrhea, and syncope was considered to be not recovered.  The lawyer considered the events of CSF pressure increased POTS, gastroparesis, fibromyalgia, aggression, gait disturbance, dysstasia, deafness, blindness, mood swings, autoimmune disorder, seizure, diarrhea, and syncope to be related to quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL).  Upon internal review, the events of CSF pressure increased, gastroparesis, deafness, blindness, seizure, and autoimmune disorder was determined to be medically significant. The events of CSF pressure increased, POTS, gastroparesis, fibromyalgia, aggression, gait disturbance, dysstasia, deafness, blindness, mood swings, autoimmune disorder, seizure, diarrhea, and syncope was considered to be disabling.